JNGLX
Price
$63.64
Change
-$0.42 (-0.66%)
Updated
May 22 closing price
Net Assets
4.66B
SHSCX
Price
$47.49
Change
-$0.34 (-0.71%)
Updated
May 22 closing price
Net Assets
6.44B
Interact to see
Advertisement

JNGLX vs SHSCX

Header iconJNGLX vs SHSCX Comparison
Open Charts JNGLX vs SHSCXBanner chart's image
Janus Henderson Global Life Sciences D
Price$63.64
Change-$0.42 (-0.66%)
VolumeN/A
Net Assets4.66B
BlackRock Health Sciences Opps Inv C
Price$47.49
Change-$0.34 (-0.71%)
VolumeN/A
Net Assets6.44B
JNGLX vs SHSCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. SHSCX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and SHSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSCX has more cash in the bank: 6.44B vs. JNGLX (4.66B). JNGLX pays higher dividends than SHSCX: JNGLX (0.34) vs SHSCX (0.00). JNGLX was incepted earlier than SHSCX: JNGLX (26 years) vs SHSCX (25 years). SHSCX (1.86) is less costly to investors than JNGLX (0.80). JNGLX is a more actively managed with annual turnover of: 35.00 vs. SHSCX (27.00). SHSCX has a lower initial minimum investment than JNGLX: SHSCX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -14.56 vs. SHSCX (-17.51). JNGLX return over 5 years is better than : 6.56 vs. SHSCX (-15.87).
JNGLXSHSCXJNGLX / SHSCX
Total Expense Ratio0.801.8643%
Annual Report Gross Expense Ratio0.801.8643%
Fund Existence26 years25 years-
Gain YTD-6.260-4.321145%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B6.44B72%
Annual Yield % from dividends0.340.00-
Returns for 1 year-14.56-17.5183%
Returns for 3 years5.57-15.70-35%
Returns for 5 years6.56-15.87-41%
Returns for 10 years6.65-6.68-100%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMIX25.04N/A
N/A
Goldman Sachs Emerging Markets Eq Instl
TLVAX22.86N/A
N/A
Timothy Plan Large/Mid Cap Value A
WFDSX30.07N/A
N/A
Allspring SMID Cap Growth Fund - Cl Inst
BCEMX24.15N/A
N/A
Boston Common ESG Impact Em Mkts
FFBGX38.27-0.02
-0.05%
American Funds Global Balanced 529-F-3